Notice Number: NOT-DK-19-022

Key Dates
Release Date: September 9, 2019

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announces its intent to participate, effective immediately, in PA-19-273 "PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)".

The following changes have been made to reflect NIDDK's participation in this FOA (changes are italicized):

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of General Medical Sciences (NIGMS)
National Institute of Mental Health (NIMH)
National Institute of Nursing Research (NINR)
National Institute on Minority Health and Health Disparities (NIMHD)
National Center for Complementary and Integrative Health (NCCIH)

Center for Global Health (CGH/CDC)
National Center on Birth Defects and Developmental Disabilities (NCBDDD/CDC)
National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP/CDC)
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID/CDC)
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP/CDC)
National Center for Immunization and Respiratory Diseases (NCIRD/CDC)
National Center for Injury Prevention and Control (NCIPC/CDC)
National Institute for Occupational Safety and Health (NIOSH/CDC)
National Center for Environmental Health (NCEH/CDC)

Center for Preparedness and Response (CPR/CDC)

Center for Biologics Evaluation and Research (CBER/FDA)
Center for Drug Evaluation and Research (CDER/FDA)
Center for Food Safety and Applied Nutrition (CFSAN/FDA)
Center for Devices and Radiological Health (CDRH/FDA)
Center for Veterinary Medicine (CVM/FDA)
Office of Critical Path Programs (CPI/FDA)
Office of Orphan Products Development (OOPD/FDA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.103; 93.061; 93.262; 93.136; 93.084; 93.068; 93.840; 93.839; 93.838; 93.837; 93.233; 93.279; 93.307; 93.865; 93.847; 93.273; 93.242; 93.859; 93.856; 93.855; 93.351; 93.143; 93.113; 93.213; 93.173; 93.399; 93.396; 93.395; 93.394; 93.393; 93.867; 93.866; 93.172; 93.073; 93.316; 93.326; 93.361

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Daniel Gossett, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-7723
Email: daniel.gossett@nih.gov